Pliant Therapeutics, Inc. (NASDAQ:PLRX) Analysts Recommend 'Buy'
Nov 3, 2024
Therapeutics Investment Portfolios
Capricor Therapeutics Unveils Long-Term HOPE-2 Study Data at the 2024 World Muscle Society Congress
Oct 4, 2024
Cognition Therapeutics Spearheads Development in Treatments for Lewy Body Dementia
Oct 2, 2024
Enliven Therapeutics Reports Promising Outcomes in Phase 1 Trial of ELVN-001 for Chronic Myeloid Leukemia
Sep 29, 2024
Sanofi's Dupixent Becomes First Biologic Approved in the US for COPD With Eosinophilic Phenotype
Sep 28, 2024
MiNK Therapeutics Announces Clinical Activity of AgenT-797 in Transplant Patient with ARDS
May 22, 2024
Rosen Law Firm Announces Deadline for Checkpoint Therapeutics Securities Class Action - CKPT
May 15, 2024
Cognition Therapeutics Completes $11.5 Million Public Stock Sale
Mar 15, 2024
Cognition Therapeutics' Research Elucidates Key Proteins in Alzheimer’s Therapy
Feb 7, 2024
The Rise of Digital Therapeutics: A Market Poised for Expansion to $21.9 Billion by 2028
Feb 3, 2024
Cognition Therapeutics CEO’s Letter Forecasts Key Milestones for Alzheimer's Disease Trial
Jan 5, 2024
Xilio Therapeutics Begins Phase 1 Trial Enrollment for XTX101 in Combination Therapy for MSS CRC
Dec 7, 2023
Hawaiian Airlines Soars on Acquisition News; Diverse Pre-Market Stock Movements Observed
Dec 4, 2023
Connect Biopharma Reports Promising Rademikibart Trial Outcomes for Atopic Dermatitis
Nov 21, 2023
Enveric Biosciences Reveals Decline in Revenue for Q3 2023 Amid Advancements of Psychedelics into Clinical Trials
Nov 15, 2023
StockNews.com Begins Coverage on Mirati Therapeutics NASDAQ:MRTX
Nov 12, 2023
StockNews.com Initiates Coverage on vTv Therapeutics VTVT
Nov 11, 2023